68150

Federal Register / Vol. 67, No. 217 / Friday, November 8, 2002 / Notices
Name of Committee: National Institute of Arthritis and Skin Diseases Special Emphasis, Panel. R03’s Small Grants for New Investigators. Date: December 16, 2002. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contract Person: Richard J. Bartlett, Ph.D., Scientific Review Administrator, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701 Democracy Plaza, Bethesda, MD 20892, (301) 594–4952. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: November 4, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02–28530 Filed 11–7–02; 8:45 am]
BILLING CODE 4140–01–M

Time: 9 am to 5 pm. Agenda: To review and evaluate grant applications. Place: Radisson Barcelo, 2121 P Street, NW., Washington, DC 20037. Contact Person: Marina L. Volkov, Ph.D., Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892–9547, (301) 435–1433. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Program Project. Date: December 16, 2002. Time: 10 am to 2 pm. Agenda: To review and evaluate grant applications. Place: Fairmont Hotel, 2401 M Street, NW., Washington, DC 20037. Contact Person: Khursheed Asghar, Ph.D., Chief, Basic Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892–9547, (301) 443–2620. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS) Dated: November 4, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02–28529 Filed 11–7–02; 8:45 am]
BILLING CODE 4140–01–M

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: November 4, 2002. LaVerne Y. Springfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02–28531 Filed 11–07–02; 8:45 am]
BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 03–27 Review of R21 Grants. Date: December 12, 2002. Time: 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: H. George Hausch, Ph.D., Acting Director, 4500 Center Drive, Natcher Building, Rm. 4AN44F, National Institute of Health, Bethesda, MD 20892, (301) 594–2372. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 03–14 Review of R44 Grants. Date: December 19, 2002. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Philip Washko, Ph.D., DMD, Scientific Review Administrator, 45 Center Drive, Natcher Building, Rm. 4AN44F, National Institute of Health, Bethesda, MD 20892, (301) 594–2372. Name of Committee: National Institute of Dental and Craniofacial Research Special

DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Bone Marrow. Date: December 2, 2002. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: 1 Democracy, 6701 Democracy Blvd., Suite 707 MSC 4879, (Telephone Conference Call). Contact Person: Tracy A. Shahan, Ph.D., Scientific Review Administrator, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Natcher Building, MSC 6500, 45 Center Drive, 5AS–25H, Bethesda, MD 20892, (301) 594–4952.

DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

VerDate 0ct<31>2002

16:24 Nov 07, 2002

Jkt 200001

PO 00000

Frm 00065

Fmt 4703

Sfmt 4703

E:\FR\FM\08NON1.SGM

08NON1

Federal Register / Vol. 67, No. 217 / Friday, November 8, 2002 / Notices
Emphasis Panel, 03–28 Review of R01 Grants. Date: December 20, 2002. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Philip Washko, Ph.D., DMD, Scientific Review Administrator, 45 Center Drive, Natcher Building, Rm. 4AN44F, National Institute of Health, Bethesda, MD 20892, (301) 594–2372. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: November 4, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02–28532 Filed 11–7–02; 8:45 am]
BILLING CODE 4140–01–M

68151

DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel, FamilyBased Interventions to Influence Diet and Physical Activity. Date: November 14, 2002. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Michael Micklin, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892, (301) 435– 1258, micklinm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Name of Committee: Center for Scientific Review Special Emphasis Panel, ZRG1 BBCB (1) 40 Chemistry/Biophysics Program Project Panel. Date: November 18, 2002. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: The Latham Hotel, 3000 M Street, NW., Washington, DC 20007. Contact Person: Arnold Revzin, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7824, Bethesda, MD 20892, (301) 435– 1153. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Risk for Violence. Date: November 18, 2002. Time: 2 p.m. to 3:15 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Mariela Shirley, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4112, MSC 7848, Bethesda, MD 20892, (301) 435– 3554, shirleym@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Immunology: Autoimmune Disease Antagonists. Date: November 19, 2002. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Stephen M. Nigida, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4112, MSC 7812, Bethesda, MD 20892, (301) 435– 3565. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, ZRG1 MEDB (02) Identification of Histone Gene Regulation Sequences. Date: November 21, 2002. Time: 12:30 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Alec S. Liacouras, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5154, MSC 7842, Bethesda, MD 20892, (301) 435– 1740.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Immunology Computer Modeling. Date: November 22, 2002. Time: 10 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Stephen M. Nigida, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4112, MSC 7812, Bethesda, MD 20892, (301) 435– 3565. Name of Committee: Center for Scientific Review Special Emphasis Panel, CDF R01 Conflict Reviews. Date: December 2, 2002. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard D. Rodewald, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD 20892, (301) 435–1024, rodewalr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, ZRG1 PTHA (02) M: Molecular Pharmacology of Shingosine-1-Phosphate. Date: December 2, 2002. Time: 1:15 p.m. to 2:15 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Larry Pinkus, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435– 1214. Name of Committee: Center for Scientific Review Special Emphasis Panel, BDCN–5 (05). Date: December 2, 2002. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Sherry L. Stuesse, Ph.D., Scientific Review Administrator, Division of Clinical and Population-Based Studies, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 5188, MSC 7846, Bethesda, MD 20892, stuesses@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Respiratory. Date: December 2, 2002. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Bernard F. Driscoll, Phd, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5158, MSC 7844, Bethesda, MD 20892, (301) 435– 1242.

VerDate 0ct<31>2002

17:16 Nov 07, 2002

Jkt 200001

PO 00000

Frm 00066

Fmt 4703

Sfmt 4703

E:\FR\FM\08NON1.SGM

08NON1